Recent Updates
Recently added Catalysts
ECOR Positive Sentiment Score: 70/100

electroCore to Participate at the Needham Virtual Healthcare Conference

Key Takeaway: electroCore, Inc. announced its participation in the Needham Virtual Healthcare Conference scheduled for April 10, 2025. CEO Dan Goldberger and CFO Joshua Lev will present a group session and engage in one-on-one meetings with investors. The event underscores electroCore's commitment to transparency and investor relations within the bioelectronic medicine sector. This conference offers a platform for discussing the company's advancements in non-invasive vagus nerve stimulation technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in the Needham Virtual Healthcare Conference highlights engagement with investors.
  • The CEO and CFO's presence in presentations emphasizes strong leadership.
  • Focus on innovative bioelectronic medicine aligns with current healthcare trends.

Full Press Release Details

ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place virtually on April 10, 2025.
Dan Goldberger, CEO and Joshua Lev, Chief Financial Officer, will host a group presentation at 2:15 p.m. ET and participate in one-on-one meetings throughout the day.
DATE: April 10, 2025
WEBCAST: electroCore Group Presentation
A live audio webcast and replay of the presentation will be available using the above dedicated link. Investors attending the conference who are interested in scheduling a meeting with management can do so by contacting their Needham representative, or by emailing FNK IR at ecor@fnkir.com for more information.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
ECOR Investor Relations

Tags

Frequently Asked Questions

When will electroCore present at the Needham Healthcare Conference?

electroCore will present at the Needham Virtual Healthcare Conference on April 10, 2025.

Who will represent electroCore during the conference?

Dan Goldberger, CEO, and Joshua Lev, CFO, will represent electroCore.

How can investors schedule a meeting with electroCore management?

Investors can contact their Needham representative or email FNK IR at ecor@fnkir.com.

What technology does electroCore focus on?

electroCore focuses on non-invasive vagus nerve stimulation (nVNS) technology.

Where can I find more information about electroCore?

More information can be found on their website at www.electrocore.com.

Last updated: Apr 1, 2025